NCT06072950: VRxOPUS-1

Opioid Use and Predicting Factors at the Emergency Department

Completed Last updated 10 October 2023

What this trial tests

trial testing Usual care in Pain in 149 participants. Completed in 4 September 2023.

Timeline

13 February 2023

Primary endpoint
4 September 2023

4 September 2023

Quick facts

Lead sponsor	Radboud University Medical Center
Status	Completed
Study type	OBSERVATIONAL
Enrollment	149
Start date	13 February 2023
Primary completion	4 September 2023
Estimated completion	4 September 2023
Sites	1 location across Netherlands

Drugs / interventions tested

• Usual care

Conditions studied

• Pain — all drugs for Pain →
• Pain, Acute — all drugs for Pain, Acute →

Sponsor

Radboud University Medical Center

Who can join

Adults 16 to 99, any sex, with Pain or Pain, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Increasing opioid misuse is a worldwide problem. About 10% of opioid misusers are primarily exposed to opioids at the Emergency Department (ED). This study was conducted to determine the feasibility for a clinical trial investigating the effect of Virtual Reality therapy on opioid consumption at the ED.

Methods: Adult patients were included when primarily seen by the Emergency Physician and presenting with a NRS pain score ≥4. Main objective was to identify the target population and evaluate outcome measures to sustain a trial incorporating the Oral Morphine Equivalent (OME) at the ED as the primary endpoint. Primary outcome was mean OME administered at the ED. Secondary outcomes included NRS pain scores, main symptoms and type of analgesics administered at the ED.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.